MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202441012113 A) filed by Ratnakar Cherukupally; Badikela Rama Krishna; T K Hima Bindu; Pranaya Pakir; T Ashwini; Kosika Sandeep; M Sesha Madhavi; and Dr. Shaik Harun Rasheed, Qutbullapur, Telangana, on Feb. 21, 2024, for 'development and validation of stability indicating method of immunotherapy (ctla-4) agent by reverse phase ultra performance liquid chromatography.'
Inventor(s) include Ratnakar Cherukupally; Badikela Rama Krishna; T K Hima Bindu; Pranaya Pakir; T Ashwini; Kosika Sandeep; M Sesha Madhavi; and Dr. Shaik Harun Rasheed.
The application for the patent was published on Sept. 5, under issue no. 36/2025.
According to the abstract released...